A patient with an occult malignancy may develop hemorrhage during anticoagulant, antiplatelet or thrombolytic therapy. The possibility of an occult malignancy should be considered in a patient with unexpected bleeding even if it can be explained by excessive anticoagulation. Early identification of an occult tumor can result in improved outcomes for the patient.
